Biote Corp (BTMD)
6.01
+0.23
(+3.98%)
USD |
NASDAQ |
May 03, 16:00
6.02
+0.01
(+0.17%)
After-Hours: 20:00
Biote Gross Profit Margin (Quarterly): 69.36% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 69.36% |
| September 30, 2023 | 68.90% |
| June 30, 2023 | 67.87% |
| March 31, 2023 | 69.05% |
| December 31, 2022 | 65.33% |
| September 30, 2022 | 68.22% |
| Date | Value |
|---|---|
| June 30, 2022 | 67.27% |
| March 31, 2022 | 66.95% |
| December 31, 2021 | 63.97% |
| September 30, 2021 | 65.45% |
| June 30, 2021 | 66.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.97%
Minimum
Dec 2021
69.36%
Maximum
Dec 2023
67.17%
Average
67.27%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| Teladoc Health Inc | 69.89% |
| American Shared Hospital Services | 49.42% |
| Novo Integrated Sciences Inc | 41.76% |
| Astrana Health Inc | 11.04% |
| Cryo-Cell International Inc | 72.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 2.46% |
| Return on Invested Capital | 6.03% |
| Profit Margin (Quarterly) | 16.92% |
| Operating Margin (Quarterly) | 12.05% |
| Return on Net Operating Assets | 6.37% |